All solid tumors

50SEQ is designed to support all therapeutic options for rare, refractory, or non-responsive cancers

  • Driven by FDA, NCCN and ASCO guidelines, 50SEQ testing results associate Standard of Care and outside Standard of Care therapeutic options with a focus on prioritization and support of treatment planning for the physician
  • Comprehensive and integrated services mobilizing complete workups by IHC, FISH and Next Generation Sequencing
  • Available individual markers, reflexive offerings, and flexible testing designed to meet the cost efficiencies and clinical needs for the patient and physician
  • In-network with most managed care providers

Learn more about our 50SEQ testing services.

How to Order
Test Directory

Sample Reports